0
0

Expressing the sense that the process behind Operation Warp Speed should be integrated within operations at the Food and Drug Administration.

12/30/2022, 3:48 AM

Summary of Bill HRES 876

Bill 117 H.Res. 876, titled "Expressing the sense that the process behind Operation Warp Speed should be integrated within operations at the Food and Drug Administration," is a resolution introduced in the US Congress. The resolution aims to highlight the success of Operation Warp Speed, the government's initiative to accelerate the development and distribution of COVID-19 vaccines, and calls for the integration of its processes within the operations of the Food and Drug Administration (FDA).

The resolution emphasizes the importance of streamlining and expediting the regulatory processes at the FDA to ensure timely approval of safe and effective vaccines and treatments. It acknowledges the success of Operation Warp Speed in achieving this goal and suggests that the FDA should adopt similar strategies to enhance its efficiency and effectiveness in responding to public health emergencies.

The resolution does not propose any specific legislative changes or mandates but rather expresses the opinion of Congress that the FDA should learn from the success of Operation Warp Speed and incorporate its best practices into its own operations. It serves as a symbolic statement of support for efforts to improve the FDA's regulatory processes and enhance its ability to respond to future public health crises. Overall, Bill 117 H.Res. 876 highlights the importance of collaboration and innovation in addressing public health challenges and encourages the FDA to learn from the successful strategies employed in Operation Warp Speed to better serve the American people.

Congressional Summary of HRES 876

This resolution states that the Food and Drug Administration (FDA) should, to the extent scientifically and legally possible, integrate the process behind Operation Warp Speed into FDA operations. (Operation Warp Speed was a partnership between the Department of Health and Human Services and the Department of Defense to coordinate federal efforts to accelerate the development of COVID-19 medical countermeasures, including vaccines.)

The resolution also states that the FDA should issue guidance identifying ways to accelerate drug and biological product development through clinical trials and the approval and licensure processes.

Current Status of Bill HRES 876

Bill HRES 876 is currently in the status of Bill Introduced since January 19, 2022. Bill HRES 876 was introduced during Congress 117 and was introduced to the House on January 19, 2022.  Bill HRES 876's most recent activity was Referred to the Subcommittee on Health. as of January 20, 2022

Bipartisan Support of Bill HRES 876

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
6
Democrat Cosponsors
0
Republican Cosponsors
6
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HRES 876

Primary Policy Focus

Health

Alternate Title(s) of Bill HRES 876

Expressing the sense that the process behind Operation Warp Speed should be integrated within operations at the Food and Drug Administration.
Expressing the sense that the process behind Operation Warp Speed should be integrated within operations at the Food and Drug Administration.

Comments